Abstract
Anti-LDL Receptor-Related Protein 2 (Anti-LRP2) nephropathy is a rare form of kidney disease that affects the older patients and is characterized with acute kidney injury (AKI) and progressive renal tubular injury associated with IgG immune complex deposits along the basement membrane of proximal tubules, and circulating autoantibodies to the proximal tubule brush border protein LRP2 (megalin). We present the case of a 79-year-old man who was hospitalized for worsening malaise, abdominal distention and bilateral lower extremity edema, diagnosed with AKI and had nephrotic range proteinuria. Percutaneous kidney biopsy revealed tubulointerstitial nephritis with IgG immune complex deposits along the basement membrane of proximal tubules and brush borders. Immunofluorescence staining for LRP2 (megalin) showed similar granular tubular basement membrane deposits along the proximal tubules and proximal tubule brush borders. Electron microscopy revealed global podocyte foot process effacement. The patient was started on oral prednisolone 1 mg/kg and rituximab at a dose of 375 mg/m2 once weekly for 4 weeks with gradual tapering of prednisone. This case with AKI and nephrotic syndrome highlights the significant morphologic overlap with minimal change disease and anti-LRP2 nephropathy, which is associated with autoantibodies to the tubular brush border protein LRP2/megalin.
References
Larsen CP, Trivin-Avillach C, Coles P et al (2018) LDL receptor-related protein 2 (megalin) as a target antigen in human kidney anti-brush border antibody disease. J Am Soc Nephrol 29(2):644–653
Carney EF (2018) Tubular disease: anti-LRP2 nephropathy. Nat Rev Nephrol 14(1):3
Dinesh KP, Raniele D, Michels K et al (2019) Anti-LRP2 nephropathy with abundant IgG4-positive plasma cells: a case report. Am J Kidney Dis 74(1):132–137
Rosales IA, Collins AB, do Carmo PA, Tolkoff-Rubin N, Smith RN, Colvin RB (2016) Immune complex tubulointerstitial nephritis due to autoantibodies to the proximal tubule brush border. J Am Soc Nephrol 27(2):380–384
Waldman M, Crew RJ, Valeri A et al (2007) Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2(3):445–453
Jennette JC, Falk RJ (1990) Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 16(5):432–437
Chen CL, Fang HC, Chou KJ et al (2005) Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis 45(5):818–825
Komukai D, Hasegawa T, Kaneshima N et al (2016) Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study. Nephrology (Carlton) 21(10):887–892
Stellato T, Cappelleri A, Farina M et al (2010) Severe reversible acute renal failure in idiopathic nephrotic syndrome. J Nephrol 23(6):717–724
Smith JD, Hayslett JP (1992) Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 19(3):201–213
Thomas ME, Brunskill NJ, Harris KP et al (1999) Proteinuria induces tubular cell turnover: a potential mechanism for tubular atrophy. Kidney Int 55(3):890–898
Wu X, He Y, Jing Y, Li K, Zhang J (2010) Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. OMICS 14(1):61–73
Liu WJ, Xu BH, Ye L et al (2015) Urinary proteins induce lysosomal membrane permeabilization and lysosomal dysfunction in renal tubular epithelial cells. Am J Physiol Renal Physiol 308(6):F639–649
Scita G, Di Fiore PP (2010) The endocytic matrix. Nature 463(7280):464–473
Taylor MJ, Perrais D, Merrifield CJ (2011) A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis. PLoS Biol 9(3):e1000604
Gianesello L, Priante G, Ceol M et al (2017) Albumin uptake in human podocytes: a possible role for the cubilin–amnionless (CUBAM) complex. Sci Rep 7(1):13705
Thompson A, Cattran DC, Blank M, Nachman PH (2015) Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol 26(12):2930–2937
Nixon A, Ogden L, Woywodt A, Dhaygude A (2017) Infectious complications of rituximab therapy in renal disease. Clin Kidney J 10(4):455–460
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest.
Consent to participate
The authors declare that the patient reported here have provided authorization for use of his medical records for research.
Consent for publication
All authors gave consent for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Caliskan, Y., Caza, T., Mosman, A. et al. A case of immune complex mediated tubulointerstitial disease and nephrotic syndrome: anti LRP-2 Nephropathy with diffuse podocyte effacement. J Nephrol 34, 915–919 (2021). https://doi.org/10.1007/s40620-020-00762-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-020-00762-9